The Society for Functional Precision Medicine arose out of recognition of the unmet need in matching cancer patients to the therapies best for them. We think there is tremendous utility in exposing patient tumor cells directly to the drugs that could be used to treat them in order to do this matching. We propose to bring cutting edge tools of tissue culture and analysis to bear on this strategy to create practical solutions. Our overriding mission is to accelerate the day when functional assays are a routine tool in the care of cancer patients. The SFPM welcomes the input and participation of any who are interested, including scientists and clinicians, patient advocates and regulators, academia as well as pharma and biotech.
Learn more about the SFPM in this recent podcast.